131 results
Page 2 of 7
SC 14D9/A
36cjad4i
27 Oct 23
Tender offer solicitation (amended)
4:20pm
SC TO-T/A
5i6cxdaq 4b4h9i
27 Oct 23
Third party tender offer statement (amended)
4:15pm
SC 14D9
ivuht nr7dk
13 Oct 23
Tender offer solicitation
7:11am
SC TO-T
lzvkykz1
13 Oct 23
Third party tender offer statement
6:52am
SC TO-T
EX-99
md0q4d5 v5
13 Oct 23
Third party tender offer statement
6:52am
SC TO-T
EX-99
qvtoojbt4y16sacbm5s
13 Oct 23
Third party tender offer statement
6:52am
SC TO-T
EX-99
upkkts9mp6utko
13 Oct 23
Third party tender offer statement
6:52am
SC TO-T
EX-99
zu877o2o1q1o0q 3h0dk
13 Oct 23
Third party tender offer statement
6:52am
SC TO-T
EX-99
gimijfd8svve
13 Oct 23
Third party tender offer statement
6:52am
SC TO-T
irv6ac7vjt
13 Oct 23
Third party tender offer statement
6:52am
SC14D9C
EX-99.2
py57i1pxq16
3 Oct 23
Written communication relating to third party tender offer
5:24pm
SC14D9C
EX-2.1
r05ckai6v44sr774 di5
3 Oct 23
Written communication relating to third party tender offer
7:37am
SC14D9C
uucg5au1 qa0or3qztg
3 Oct 23
Written communication relating to third party tender offer
7:37am
8-K
szbohxjr
3 Oct 23
Tender and Support Agreement
7:35am
8-K
EX-2.1
dl2nc 1gexfmbr5w4wz
3 Oct 23
Tender and Support Agreement
7:35am
8-K
EX-99.1
t4sgjbeg49iett8ao9d
14 Aug 23
POINT Biopharma Reports Second Quarter 2023 Financial Results and Provides Business Highlights
7:21am
ARS
h3vih7owaiy6w
1 May 23
Annual report to shareholders
1:52pm